These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 25193735)

  • 21. Trimetazidine Decreases Risk of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials.
    Nadkarni GN; Konstantinidis I; Patel A; Yacoub R; Kumbala D; Patel RA; Annapureddy N; Pakanati KC; Simoes PK; Javed F; Benjo AM
    J Cardiovasc Pharmacol Ther; 2015 Nov; 20(6):539-46. PubMed ID: 25715308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-cIN trial).
    Kaya A; Kurt M; Tanboğa IH; Işik T; Ekinci M; Aksakal E; Kaya Y; Topçu S; Sevimli S
    Acta Cardiol; 2013 Oct; 68(5):489-94. PubMed ID: 24283110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes.
    Marenzi G; Cosentino N; Werba JP; Tedesco CC; Veglia F; Bartorelli AL
    Int J Cardiol; 2015 Mar; 183():47-53. PubMed ID: 25662053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain natriuretic peptide for prevention of contrast-inducednephropathy: a meta-analysis of randomized controlled trials.
    Wei XB; Jiang L; Liu XR; Yu DQ; Tan N; Chen JY; Zhou YL; He PC; Liu YH
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1311-1318. PubMed ID: 27695914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
    Bei WJ; Duan CY; Chen JY; Wang K; Liu YH; Liu Y; Tan N
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):53-63. PubMed ID: 26112028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of atorvastatin on the prevention of contrast-induced acute kidney injury: a meta-analysis.
    Liu LY; Liu Y; Wu MY; Sun YY; Ma FZ
    Drug Des Devel Ther; 2018; 12():437-444. PubMed ID: 29535505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of statin therapy on contrast-induced nephropathy after coronary angiography: a meta-analysis.
    Pappy R; Stavrakis S; Hennebry TA; Abu-Fadel MS
    Int J Cardiol; 2011 Sep; 151(3):348-53. PubMed ID: 21636154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Furosemide with saline hydration for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a meta-analysis of randomized controlled trials.
    Duan N; Zhao J; Li Z; Dong P; Wang S; Zhao Y; Wang L; Wang H
    Med Sci Monit; 2015 Jan; 21():292-7. PubMed ID: 25613017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy After Coronary Angiography or Percutaneous Coronary Intervention in Patients With Diabetes.
    Zhang MM; Lv QZ; Li XY
    Am J Ther; 2017; 24(4):e423-e430. PubMed ID: 26308327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term, high-dose statins in the prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
    Zhou Y; Yuan WJ; Zhu N; Wang L
    Clin Nephrol; 2011 Dec; 76(6):475-83. PubMed ID: 22105451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose atorvastatin for preventing contrast-induced nephropathy in primary percutaneous coronary intervention.
    Jo SH; Hahn JY; Lee SY; Kim HJ; Song YB; Choi JH; Choi SH; Lee SH; Gwon HC
    J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):213-9. PubMed ID: 25032713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effects of short-term high-dose statins on the prevention of contrast-induced nephropathy in patients undertaking coronary angiography: a systematic review and meta-analysis].
    Zhou Y; Yuan WJ
    Zhonghua Nei Ke Za Zhi; 2011 Nov; 50(11):942-6. PubMed ID: 22333127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast-induced nephropathy: do statins offer protection?
    Sadat U
    Curr Opin Cardiol; 2011 Jul; 26(4):334-7. PubMed ID: 21537166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization.
    Giacoppo D; Capodanno D; Capranzano P; Aruta P; Tamburino C
    Am J Cardiol; 2014 Aug; 114(4):541-8. PubMed ID: 25001154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
    Zhang T; Shen LH; Hu LH; He B
    Am J Nephrol; 2011; 33(4):344-51. PubMed ID: 21430372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.
    Zagler A; Azadpour M; Mercado C; Hennekens CH
    Am Heart J; 2006 Jan; 151(1):140-5. PubMed ID: 16368307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Liu Y; Hong D; Wang AY; Guo R; Smyth B; Liu J; Sun G; Chen S; Tan N; Jardine M; Brieger D; Shaman A; Islam S; Chen J; Gallagher M
    BMC Cardiovasc Disord; 2019 Apr; 19(1):87. PubMed ID: 30961544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of rosuvastatin efficacy in prevention of contrast-induced acute kidney injury.
    Zhang J; Guo Y; Jin Q; Bian L; Lin P
    Drug Des Devel Ther; 2018; 12():3685-3690. PubMed ID: 30464400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
    Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins for the prevention of contrast-induced acute kidney injury.
    Ball T; McCullough PA
    Nephron Clin Pract; 2014; 127(1-4):165-71. PubMed ID: 25343843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.